Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
WHCS.AS
152
HOLDINGS
21%
ALSO IN XSDR.DE
XSDR.DE
29
HOLDINGS
89%
ALSO IN WHCS.AS
SECTOR DRIFT (WHCS.AS minus XSDR.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WHCS.AS |
Weight in XSDR.DE |
Overlap | |
|---|---|---|---|---|
 |
NOVARTIS AG | 5.1% | 16.5% | 5.1% |
 |
ASTRAZENECA PLC | 3.7% | 17.7% | 3.7% |
 |
NOVO NORDISK A/S-B | 2.5% | 11.1% | 2.5% |
|
ALCON, INC. | 1.4% | 2.4% | 1.4% |
 |
ESSILOR INTERNATIONAL | 1.0% | 6.0% | 1.0% |
WHCS.AS Overweight Relative to XSDR.DE
 |
ELI LILLY & CO | 10.2% |
|
JOHNSON & JOHNSON | 4.8% |
|
ABBVIE INC | 4.5% |
|
UNITEDHEALTH GROUP INC | 3.4% |
|
MERCK & CO. INC. | 2.8% |
|
GILEAD SCIENCES INC | 2.7% |
|
ROCHE HOLDING AG-BR | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
|
THERMO FISHER SCIENTIFIC INC | 2.0% |
|
CENCORA INC | 1.9% |
WHCS.AS Underweight Relative to XSDR.DE
|
ROCHE HOLDING LTD | -18.4% |
|
ROCHE HOLDING AG-GENUSSCHEIN | -18.4% |
|
NOVARTIS AG-REG | -16.5% |
|
ASTRAZENECA PLC | -14.0% |
|
NOVARTIS AG | -11.3% |
|
NOVO NORDISK A/S-B | -8.6% |
|
SANOFI-AVENTIS | -5.6% |
|
ESSILOR INTERNATIONAL | -5.0% |
|
LONZA GROUP AG-REG | -2.9% |
 |
ARGEN-X SE | -2.5% |